The Prospective Collection, Storage and Reporting of Data on Patients
Summary
To provide the IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed.
Detailed description
To provide an IRB approved mechanism for the prospective collection and analysis on participants who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant or cellular therapies for a disease in which a research question is not being addressed and for which peer reviewed, published data have demonstrated efficacy for this treatment approach. To provide a consent mechanism for the retrospective study of cellular products, when available, if there is a specific question to be addressed.
Outcome measures
Primary
Data followup
Gather basic survival and complication data for operational and research databases for ongoing regulatory and future operational queries
Time frame: 1 year
Eligibility criteria
Study locations (1)
Wake Forest Baptist Health
Winston-Salem, North Carolina, 27157